Hansa Biopharma GAAP EPS of -SEK 2.53, revenue of SEK 49.1M
Source: SeekingAlpha
2025-07-17 02:47:58 ET
More on Hansa Biopharma
- Hansa Biopharma AB (publ) (HNSBF) Q1 2025 Earnings Call Transcript
- Hansa Biopharma AB (publ) 2025 Q1 - Results - Earnings Call Presentation
- Historical earnings data for Hansa Biopharma
- Financial information for Hansa Biopharma
Read the full article on Seeking Alpha
For further details see:
Hansa Biopharma GAAP EPS of -SEK 2.53, revenue of SEK 49.1M
Hansa Biopharma AB
NASDAQ: HNSBF
HNSBF Trading
-85.0% G/L:
$2.91 Last:
28,750 Volume:
$2.91 Open:
HNSBF Latest News
September 24, 2025 02:06:00 pm
Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
